Short Courses*

March 1-3, 2020 | Moscone South Convention Center

Cambridge Healthtech Institute is pleased to offer short courses taking place on Sunday-Tuesday at the Moscone South Convention Center. The short courses are designed to be instructional, interactive, and provide in-depth information on a specific topic. They allow for one-on-one interaction and provide a great way to explain more technical aspects that would otherwise not be covered during the main conference programs that take place Monday-Wednesday.

Sunday, March 1 | 2:00 - 5:00 pm (Afternoon Short Courses)

SC2: Development and Implementation of NGS Diagnostics for Precision Medicine - Detailed Agenda

Karl V. Voelkerding, MD, Professor, Pathology, University of Utah; Medical Director for Genomics and Bioinformatics, ARUP Laboratories

Joshua Coleman, MD, Assistant Professor, Pathology, University of Utah, Medical Director for Molecular Oncology, ARUP Laboratories

Jillian Buchan, PhD, Clinical Assistant Professor, Pathology, Stanford University

SC4: Introduction to Data Visualization for Biomedical Applications - Detailed Agenda

Nils Gehlenborg, PhD, Assistant Professor, Department of Biomedical Informatics, Harvard Medical School

Alexander Lex, PhD, Assistant Professor, SCI Institute, School of Computing, University of Utah

SC5: Artificial Intelligence and Machine Learning in Drug Discovery and Development – Part 1 - Detailed Agenda

Michael Liebman, PhD, Managing Director, IPQ Analytics, LLC

Stefan Harrer, PhD, Manager and Research Staff Member, Brain-Inspired Computing, IBM Research; Adjunct Professor, School of Engineering and Information Science, University of Technology Sydney

Pankaj Agarwal, PhD, Chief Computational Biologist, BioInfi

Deepak Kumar Rajpal, PhD, Head, Bioinformatics, Translational Sciences, Sanofi

Arvind Rao, PhD, Associate Professor, Department of Computational Medicine and Bioinformatics, University of Michigan

SC6: Translating CTCs and ctDNA for Clinical Use - Detailed Agenda

Sonya Parpart-Li, PhD, RAC, Associate Director, Product Management, GRAIL, Inc.

Gozde Durmus, PhD, Assistant Professor, Department of Radiology, Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine

Prachi Kothari, DO, Assistant Attending, Department of Pediatrics, Memorial Sloan Kettering Cancer Center

Sunday, March 1 | 5:30 - 8:30 pm (Dinner Short Courses)

SC9: Companion Diagnostics for Immuno-Oncology - Detailed Agenda

Kenneth Emancipator, MD, Executive Medical Director and Head of Companion Diagnostics, Merck & Co., Inc.

Lakshman Ramamurthy, PhD, Senior Director, Global Regulatory Affairs, Oncology, GlaxoSmithKline

Mary J. Savage, Senior Director, Companion Diagnostics, GlaxoSmithKline

SC10: Microfluidics and Other Devices for POCT - Detailed Agenda

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Kris Buchanan, CEO,   Phase Three Product Development

 Additional Instructors to be Announced

SC12: Liquid Biopsy Technologies and Applications - Detailed Agenda

John Simmons, PhD, Vice President, Translational Medicine, Personal Genome Diagnostics

SC13: Artificial Intelligence and Machine Learning in Drug Discovery and Development – Part 2 - Detailed Agenda

Michael Liebman, PhD, Managing Director, IPQ Analytics, LLC

Stefan Harrer, PhD, Manager and Research Staff Member, Brain-Inspired Computing, IBM Research; Adjunct Professor, School of Engineering and Information Science, University of Technology Sydney

Shruthi Bharadwaj, PhD, Senior Scientist, Novartis Oncology Precision Medicine

Kuan-Fu Ding, MSc, PhD, Chief Science Officer, Catalytic Data Science

Monday, March 2 | 8:00 - 11:00 am (Morning Short Courses)

SC17: NGS as a Testing Platform: Technology, Clinical Applications, and Global Standardization Strategies - Detailed Agenda

Annette Leon, PhD, FACMG, CGMBS, CCS, Head, Clinical Reporting, Color Inc.

Kristin McDonald Gibson, PhD, FACMG, Associate Laboratory Director, Invitae

Bert Gold, PhD, FACMG, CGMBS, Principal Consultant, Gold Standard Genetics LLC

Junaid Shabbeer, PhD, FACMG, Senior Laboratory Directory, Ariosa Diagnostics, Roche Sequencing Solutions

SC18: Commercialization Boot Camp for Diagnostics: State of the State** - Detailed Agenda

Harry Glorikian, MBA, General Partner, New Ventures Funds

Stan Skrzypczak, MS, MBA, Founder, 5 Prime Life Science Consulting, Inc.

SC19: NGS for Infectious Disease Diagnostics - Detailed Agenda

Charles Chiu, MD, PhD, Associate Professor, Lab Medicine and Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, Clinical Microbiology Laboratory, University of California, San Francisco

SC21: Liquid Biopsy: Detection, Characterization, and Clinical Applications of Circulating Biomarkers - Detailed Agenda

Catherine Alix-Panabières, PhD, Director, Laboratory of Rare Human Circulating Cells (LCCRH), Pathology and Onco-Biology Department, University Medical Center of Montpellier, France

Klaus Pantel, MD, Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg, Germany

SC22: Digital Medicine 101 - Detailed Agenda

Elena Izmailova, PhD, CSO, Koneksa Health

Joris van Dam, PhD, Head, Digital Therapeutics, Novartis Institutes for BioMedical Research

Tuesday, March 3 | 6:30 - 9:30 pm (Dinner Short Courses)

SC25: Coverage and Reimbursement for Advanced Diagnostics - Detailed Agenda

Katherine Tynan, PhD, CEO, President, Tynan Consulting LLC

Lon Castle, MD, CMO, Lab and Specialty Drug Services, eviCore healthcare

Victoria Pratt, PhD, FACMG, Director, Pharmacogenomics and Molecular Genetics Laboratories, Medical and Molecular Genetics, Indiana University School of Medicine; President, Association of Molecular Pathology

Bruce Quinn, MD, PhD, Principal, Bruce Quinn Associates

SC26: Gene Editing and Base Editing for Cell Therapies - Detailed Agenda

Clifford Steer, MD, Professor of Medicine and, Genetics, Cell Biology, and Development, University of Minnesota Medical School

Ross Wilson, PhD, Project Scientist & Principal Investigator, Innovative Genomics Institute, California Institute for Quantitative Biosciences, University of California, Berkeley

Beau Webber, PhD, Assistant Professor, Department of Pediatrics, Division of Hematology and Oncology, University of Minnesota

SC27: Early Cancer Detection - Detailed Agenda

Nicholas Dracopoli, PhD, CSO, DELFI Diagnostics

Anne-Renee Hartman, MD, Biotech Executive, Advisor, and Investor

Girish Putcha, MD, CMO, Clinical Laboratory Director, Freenome

SC28: Global Companion Diagnostic Commercialization Boot Camp - Detailed Agenda

Charles Mathews, Principal, ClearView Healthcare Partners

Julie Ramage, Director, Precision Medicine Quality Initiatives and Partnerships, AstraZeneca

Rob Dumanois, Manager Reimbursement Strategy, Clinical Next-Generation Sequencing Division, Thermo Fisher Scientific

SC29: How Molecular Multiplex Testing for Infectious Disease Is Shaping Up - Detailed Agenda

Lawrence J. Worden, Founder, Principal, IVD Logix

Lucy Hattingh, MBA, Principal, Lucy Hattingh Consulting

Joen T. Johansen, President, MDC Associates, Inc.


*Separate Registration is required, or choose up to 3 in the All Access Pass.


Premier Sponsors

NeoGenomics

Seegene